Immunology
Pioneering Science, Inspired By Patients
Living with inflammatory diseases, greatly impacts patients’ lives emotionally and physically. These patients are our guide, partner and inspiration as we redefine treatment paradigms. As a family-owned company, we can plan long-term. Our people work every day with integrity and passion to deliver advances in hard-to-treat inflammatory diseases of the lung, gut, skin and joints. Our goal is to discover and develop first-of-their-kind therapies. With a deep understanding of molecular pathways, we are pioneering scientific breakthroughs that target, repair and prevent many inflammatory diseases. By building on long-term collaborations with the patient community, researchers, start-ups and healthcare authorities, we strive to bring treatment breakthroughs to patients in the shortest time. We won’t rest until we can give people the chance to live the life they want.
-
GPP: there is more than you see
Immunology
Learn about Generalized Pustular Psoriasis and how it affects people living with it
-
The IL-36 pathway and pustular psoriasis
-
EURORDIS Black Pearl AWARDS
Scleroderma
EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020
-
Generalised Pustular Psoriasis (GPP)
DOWNLOAD PDF (2.24 MB)
Facts about a rare and chronic autoinflammatory skin disease
-
Let's get connected
Palmoplantar Pustulosis
It is World Psoriasis Day (WPD) today and we had the opportunity to talk to Ingvar Ágúst Ingvarsson, Vice President, and Patrik Vuorio, Executive Director, about this year’s WPD campaign, their work at the IFPA and the organisation’s vision for the future
-
Palmoplantar Pustulosis (PPP)
DOWNLOAD PDF (719.99 KB)
Facts about a rare and chronic autoinflammatory skin disease
-
Unlocking Novel Biology in Immunology
Disease Focus
Find out more about our ‘Blunt, Repair, Block’ approach to immunology research.
-
Dr. Sudha Visvanathan
Disease Focus
Find out how translational medicine is helping bring transformational therapies to patients
-
Jay Fine
Disease Focus
Hear from Jay Fine, Global Head of Immunology and Respiratory Diseases Research, about Boehringer Ingelheim’s innovative work on the IL 36 pathway
-
Working Together in Immunology
Partnering Interests
-
Immunology